Investor Presentaiton slide image

Investor Presentaiton

DNA IFRS 16 impact on DNA's Income Statement and Balance Sheet in 2019 Impact of IFRS 16 is mainly coming from long-term leasing contracts of premises, equipment facilities and leasing cars ā†’ Instead of leasing expenses, depreciation and interests will be recorded into the income statement: " " Liabilities increase about EUR 81 million and property, plant and equipment about EUR 84 million EBITDA, positive impact of about EUR 17 million Depreciation increase about EUR 17 million Finance expenses increase about EUR 1 million Net debt/EBITDA ratio will deteriorate about 0.2 Investments will increase about EUR 8 million. IFRS 16 won't have an impact on operative capex. EUR, million Net sales 2019 Other operating expenses -17 EBITDA 17 Depreciation, amortisation and impairments 17 Operating result, EBIT 0 Financial expenses 1 -1 Net result before income tax DNA's Financial Statements Bulletin 2018 39
View entire presentation